Shows maternal IL-17A predicts GBS transmission risk in newborns, indicating potential interventions.
This study shows that GBS-colonized-mothers may exhibit a greater cytokine inflammatory response compared to non-colonized-mothers. Regarding mother-newborn dyads, maternal IL-17A, a key mediator of antibacterial defense, emerges as a significant prognostic biomarker for assessing the risk of GBS transmission and the development of neonatal GBS invasive disease.
No takes yet. Share an insight, caveat, or question.
Amar et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: